drugset / Trial / NCT02098174

Pharmacokinetics of MP-3180 in Healthy Volunteers

NCT02098174

Phase 1 Completed 16 enrolled MediBeacon
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study was to investigate the pharmacokinetics of MP-3180 (1 µmol/kg) compared to the pharmacokinetics of iohexol (5 mL of a 300 mg iodine (I)/mL solution) in healthy adult participants. The secondary objective was to evaluate the safety and tolerability of MP-3180 in healthy adult participants.

Timeline

Start
2013-11
Primary completion
2014-01
Completion
2014-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Iohexol Diagnostic / imaging agent 5 ml Intravenous
Subject MP-3180 Diagnostic / imaging agent 0.372 mg/kg Intravenous

Indications